Despite the integration of self-screening and mammography into women’s healthcare systems, breast cancer remains the most frequently diagnosed cancer in the EU. In 2023, it accounted for approximately 380,000 cases, or 13.8% of all cancer diagnoses. This highlights the importance of continuous advancements in early detection and treatment methods. While significant efforts have been made to catch the disease early, breast cancer still causes 7.5% of cancer-related deaths, behind lung and colorectal cancers in terms of mortality.
The exom solution opens new avenues for research through real-time epidemiology. It streamlines the management of analyses by focusing on the most relevant locations and types of tests. Rather than relying on traditional practices, exom prioritizes analyses that yield the most valuable data. This approach enhances the precision of diagnostics and the quality of treatments, ensuring that decisions are based on the most informative and impactful insights, contributing to more efficient, data-driven healthcare and research.
Don't loose anymore medical time searching and transmitting information
Get more precise diagnostics with our integrated AI solutions
The Dataset is defined with the local data and never share extzernally. In the analysis details, you can view who has also access to the data.
AI and datadriven medicine make sens only with a team working spirit. T'ats why we integrated share and chats for professionals.